← Open Payments lookup

TILDA MARTIN: Open Payments

NPI 1942676424 · MINDEN, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$418 in 29 payments from 8 companies in 2025. Trend: 2023 $358 · 2024 $622 · 2025 $418

Food & beverage: $418
CompanyPaymentsAmount
Novo Nordisk Inc17$163
ABBVIE INC.4$100
AstraZeneca Pharmaceuticals LP2$40
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$32
PFIZER INC.1$31
Astellas Pharma US Inc1$21
GlaxoSmithKline, LLC.1$16
Lilly USA, LLC1$15

Products named: Ozempic, VRAYLAR, Rybelsus, CAPLYTA, NURTEC ODT, UBRELVY, Veozah, TRELEGY ELLIPTA.

Industry payments across NV — which companies pay providers there.